Literature DB >> 15081608

Continuous-flow UVC irradiation: a new, effective, protein activity-preserving system for inactivating bacteria and viruses, including erythrovirus B19.

Perrine Caillet-Fauquet1, Mario Di Giambattista, Marie-Louise Draps, Flavienne Sandras, Theo Branckaert, Yvan de Launoit, Ruth Laub.   

Abstract

Despite the increasing number of screening tests being introduced, ensuring the inactivation of blood-borne pathogens in blood-derived therapeutic material is a major concern. Dynamic continuous-flow UVC irradiation is a new way to inactivate a large range of pathogens without adding any photosentizers. The efficacy of different methods was evaluated against the following viruses: murine parvovirus MVMp, human B19, the encephalomyocarditis virus (EMC, a picornavirus used as a model for model for hepatitis A virus), and bovine herpes virus type 1 (BHV, a model for enveloped viruses such as hepatitis B virus). We show that continuous-flow UVC irradiation is very effective, particularly against resistant pathogens (e.g. parvoviruses and bacteria) at UVC doses preserving protein activity. It may be applicable to newly emerging related viruses or variants.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15081608     DOI: 10.1016/j.jviromet.2004.02.002

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  10 in total

1.  UV-C irradiation disrupts platelet surface disulfide bonds and activates the platelet integrin alphaIIbbeta3.

Authors:  Robin Verhaar; David W C Dekkers; Iris M De Cuyper; Mark H Ginsberg; Dirk de Korte; Arthur J Verhoeven
Journal:  Blood       Date:  2008-09-16       Impact factor: 22.113

2.  Parvovirus B19 - Revised.

Authors:  Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen; Carl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2010-11-17       Impact factor: 3.747

3.  UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma.

Authors:  Axel Seltsam; Thomas H Müller
Journal:  Transfus Med Hemother       Date:  2011-01-22       Impact factor: 3.747

Review 4.  UVC-based photoinactivation as an efficient tool to control the transmission of coronaviruses.

Authors:  Sanjeev K Bhardwaj; Harpreet Singh; Akash Deep; Madhu Khatri; Jayeeta Bhaumik; Ki-Hyun Kim; Neha Bhardwaj
Journal:  Sci Total Environ       Date:  2021-06-16       Impact factor: 7.963

5.  Disrupting the transmission of influenza a: face masks and ultraviolet light as control measures.

Authors:  Martin Meyer Weiss; Peter D Weiss; Danielle E Weiss; Joseph B Weiss
Journal:  Am J Public Health       Date:  2007-04-05       Impact factor: 9.308

Review 6.  Viral genes as oncolytic agents for cancer therapy.

Authors:  Shishir Kumar Gupta; Ravi Kumar Gandham; A P Sahoo; A K Tiwari
Journal:  Cell Mol Life Sci       Date:  2014-11-19       Impact factor: 9.207

7.  Ultraviolet Light (UV) Inactivation of Porcine Parvovirus in Liquid Plasma and Effect of UV Irradiated Spray Dried Porcine Plasma on Performance of Weaned Pigs.

Authors:  Javier Polo; Carmen Rodríguez; Jesús Ródenas; Louis E Russell; Joy M Campbell; Joe D Crenshaw; David Torrallardona; Joan Pujols
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

Review 8.  Virus safety of intravenous immunoglobulin: future challenges.

Authors:  Nicola Boschetti; Martin Stucki; Peter J Späth; Christoph Kempf
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

Review 9.  Evaluating ultraviolet sensitivity of adventitious agents in biopharmaceutical manufacturing.

Authors:  Sarah M Meunier; Michael R Sasges; Marc G Aucoin
Journal:  J Ind Microbiol Biotechnol       Date:  2017-03-10       Impact factor: 3.346

10.  Pathogen reduction through additive-free short-wave UV light irradiation retains the optimal efficacy of human platelet lysate for the expansion of human bone marrow mesenchymal stem cells.

Authors:  Sabrina Viau; Lucie Chabrand; Sandy Eap; Judith Lorant; Karl Rouger; Francis Goudaliez; Chryslain Sumian; Bruno Delorme
Journal:  PLoS One       Date:  2017-08-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.